2022
DOI: 10.1016/j.preteyeres.2021.101021
|View full text |Cite
|
Sign up to set email alerts
|

Age and intraocular pressure in murine experimental glaucoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 239 publications
0
8
0
Order By: Relevance
“…A main hurdle in developing new therapies and understanding the molecular mechanism of glaucoma is the lack of an animal model that recapitulates all aspects of the disease. While some laboratories focus on developing animal models of chronic IOP elevation, others use mice with natural mutations that slowly develop age‐related hypertension and RGC loss (Di Pierdomenico et al, 2022 ). We have been particularly interested in studying an animal model that allow us to capture the time course of molecular changes upon glaucomatous stress, such as mild ocular hypertension.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A main hurdle in developing new therapies and understanding the molecular mechanism of glaucoma is the lack of an animal model that recapitulates all aspects of the disease. While some laboratories focus on developing animal models of chronic IOP elevation, others use mice with natural mutations that slowly develop age‐related hypertension and RGC loss (Di Pierdomenico et al, 2022 ). We have been particularly interested in studying an animal model that allow us to capture the time course of molecular changes upon glaucomatous stress, such as mild ocular hypertension.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, our molecular analysis detects senescence as one of the pathways involved in the response to stress mechanism of the retina upon IOP elevation, what we previously documented in human glaucomatous tissue(Skowronska-Krawczyk et al, 2015).A main hurdle in developing new therapies and understanding the molecular mechanism of glaucoma is the lack of an animal model that recapitulates all aspects of the disease. While some laboratories focus on developing animal models of chronic IOP elevation, others use mice with natural mutations that slowly develop agerelated hypertension and RGC loss(Di Pierdomenico et al, 2022).We have been particularly interested in studying an animal model that allow us to capture the time course of molecular changes upon glaucomatous stress, such as mild ocular hypertension. Since age is the strongest risk factor for developing glaucoma, we developed and characterized the aged animal model for our future molecular studies.The molecular analysis of transcriptional changes between IOP-treated and non-treated retinas has detected a high numberF I G U R E 4 ATAC-seq analysis of stress-related epigenetic change.…”
mentioning
confidence: 99%
“…Age and elevated intraocular pressure (IOP) are the two primary risk factors for glaucoma [1][2][3][4][5][6], the leading cause of irreversible blindness [7]. For example, glaucoma prevalence increases from 0.2% to 2.7% between the ages of 50 and 59 can reach 12.8% in those over 80 [6,[8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…There are several markers that allow the identification of large populations of rodent RGCs (pan-markers) such as Brn3a or RBPMS ( Nadal-Nicolas et al, 2023 ) or specific related RGCs groups, also named subclasses, such as the intrinsically photosensitive RGCs ( Vidal-Villegas et al, 2021a , b ) or the alfa RGCs (αRGCs; Gallego-Ortega et al, 2022 ), among others ( Tran et al, 2019 ). Immunohistochemical studies using a combination of markers allow the study, in parallel but independently, of how different RGCs respond to different retinal injuries ( Vidal-Sanz et al, 2015a ; Agudo-Barriuso et al, 2016 ; Di Pierdomenico et al, 2022b ) and protection ( Valiente-Soriano et al, 2015 ; Rovere et al, 2016 ; Sanchez-Migallon et al, 2018 ). For instance, the expression of Brn3a by rodent RGCs has allowed to identification of the main population of RGCs, which accounts for approximately 96% of the RGC population ( Nadal-Nicolas et al, 2014 ).…”
Section: Introductionmentioning
confidence: 99%